APT Medical's (SHA:688617) net profit attributable to shareholders in 2024 rose 26% to 673.2 million yuan from 533.9 million yuan a year earlier, according to a Wednesday filing with the Shanghai Stock Exchange.
Earnings per share climbed 27% year on year to 6.92 yuan from 5.46 yuan.
The Chinese medical device company's operating income in the same period inched 25% higher to 2.07 billion yuan from 1.65 billion yuan in the previous year, the filing said.
The company's shares dropped 4% in recent trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。